Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2017

03.01.2017 | Original Article

Multicenter Prospective Study on the Safety of Upper Gastrointestinal Endoscopic Procedures in Antithrombotic Drug Users

verfasst von: Yoshiyasu Kono, Minoru Matsubara, Tatsuya Toyokawa, Ryuta Takenaka, Seiyu Suzuki, Junichirou Nasu, Masao Yoshioka, Masahiro Nakagawa, Motowo Mizuno, Hiroyuki Sakae, Makoto Abe, Tatsuhiro Gotoda, Ko Miura, Hiromitsu Kanzaki, Masaya Iwamuro, Keisuke Hori, Takao Tsuzuki, Masahide Kita, Seiji Kawano, Yoshiro Kawahara, Hiroyuki Okada

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The Japan Gastroenterological Endoscopy Society updated its guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment in July 2012. However, the safety of endoscopic procedures in antithrombotic drug users has not been fully investigated.

Aims

To evaluate the safety of upper gastrointestinal endoscopic procedures in antithrombotic drug users.

Methods

From September 2013 to September 2015, patients who were taking antithrombotic drugs and who underwent upper gastrointestinal endoscopic procedures were prospectively enrolled at five hospitals. Incidences of bleeding and thrombosis during endoscopic procedures were evaluated.

Results

A total of 270 patients [221 for endoscopic mucosal biopsy and 49 for endoscopic mucosal resection (EMR)/endoscopic submucosal dissection (ESD) were enrolled. The bleeding rate was 0.9% for endoscopic mucosal biopsy and 22% for EMR/ESD, respectively. The bleeding rate after endoscopic mucosal biopsy was not significantly high, even if antithrombotic drugs were continued (0 vs. 1%, P > 0.99), while it was significantly higher among multiple antithrombotic drug users than single drug users (5.9 vs. 0%, P < 0.05). The bleeding rate after EMR/ESD was also higher among multiple antithrombotic drug users than single drug users, but was not significantly different (33 vs. 14%, P = 0.17). Moreover, there were no differences in bleeding rates according to the cessation or continuance of antithrombotic drugs (20 vs. 25%, P = 0.74). There were no thromboembolisms in all cases.

Conclusions

Upper gastrointestinal endoscopic procedures performed under the new guidelines appear acceptable. However, endoscopic procedures among multiple antithrombotic drug users show a greater potential for bleeding.
Literatur
1.
Zurück zum Zitat Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med.. 2013;368:2113–2124.CrossRefPubMed Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med.. 2013;368:2113–2124.CrossRefPubMed
2.
Zurück zum Zitat Nadatani Y, Watanabe T, Tanigawa T, et al. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan. Scand J Gastroenterol.. 2013;48:320–325.CrossRefPubMed Nadatani Y, Watanabe T, Tanigawa T, et al. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan. Scand J Gastroenterol.. 2013;48:320–325.CrossRefPubMed
3.
Zurück zum Zitat Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ. 2006;333:726.CrossRefPubMedPubMedCentral Hallas J, Dall M, Andries A, et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ. 2006;333:726.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Lee SY, Tang SJ, Rockey DC, et al. Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc.. 2008;67:1076–1081.CrossRefPubMed Lee SY, Tang SJ, Rockey DC, et al. Managing anticoagulation and antiplatelet medications in GI endoscopy: a survey comparing the East and the West. Gastrointest Endosc.. 2008;67:1076–1081.CrossRefPubMed
5.
Zurück zum Zitat Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc.. 2016;83:3–16.CrossRefPubMed Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc.. 2016;83:3–16.CrossRefPubMed
6.
Zurück zum Zitat Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol.. 2005;62:1217–1220.CrossRefPubMed Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol.. 2005;62:1217–1220.CrossRefPubMed
7.
Zurück zum Zitat Garcia DA, Regan S, Henault LE, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med.. 2008;168:63–69.CrossRefPubMed Garcia DA, Regan S, Henault LE, et al. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med.. 2008;168:63–69.CrossRefPubMed
8.
Zurück zum Zitat van Hattum ES, Algra A, Lawson JA, Eikelboom BC, Moll FL, Tangelder MJ. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease. Circulation. 2009;120:1569–1576.CrossRefPubMed van Hattum ES, Algra A, Lawson JA, Eikelboom BC, Moll FL, Tangelder MJ. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease. Circulation. 2009;120:1569–1576.CrossRefPubMed
9.
Zurück zum Zitat Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc.. 2014;26:1–14.CrossRefPubMed Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc.. 2014;26:1–14.CrossRefPubMed
10.
Zurück zum Zitat Hirasawa K, Kokawa A, Oka H, et al. Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection. Gastrointest Endosc.. 2011;74:1268–1275.CrossRefPubMed Hirasawa K, Kokawa A, Oka H, et al. Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection. Gastrointest Endosc.. 2011;74:1268–1275.CrossRefPubMed
11.
Zurück zum Zitat Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–225.CrossRefPubMed Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–225.CrossRefPubMed
12.
Zurück zum Zitat Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc.. 2002;56:387–390.CrossRefPubMed Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc.. 2002;56:387–390.CrossRefPubMed
13.
Zurück zum Zitat Katada C, Muto M, Momma K, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae-a multicenter retrospective cohort study. Endoscopy. 2007;39:779–783.CrossRefPubMed Katada C, Muto M, Momma K, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae-a multicenter retrospective cohort study. Endoscopy. 2007;39:779–783.CrossRefPubMed
14.
Zurück zum Zitat Fujita M, Shiotani A, Murao T, et al. Safety of gastrointestinal endoscopic biopsy in patients taking antithrombotics. Dig Endosc.. 2015;27:25–29.CrossRefPubMed Fujita M, Shiotani A, Murao T, et al. Safety of gastrointestinal endoscopic biopsy in patients taking antithrombotics. Dig Endosc.. 2015;27:25–29.CrossRefPubMed
15.
Zurück zum Zitat Tounou S, Morita Y, Hosono T, et al. Endoscopic submucosal dissection for early gastric cancer without interruption of warfarin and aspirin. Endosc Int Open. 2015;3:E307–E310.CrossRefPubMedPubMedCentral Tounou S, Morita Y, Hosono T, et al. Endoscopic submucosal dissection for early gastric cancer without interruption of warfarin and aspirin. Endosc Int Open. 2015;3:E307–E310.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Mabe K, Kato M, Oba K, et al. A prospective, multicenter survey on the validity of shorter periendoscopic cessation of antithrombotic agents in Japan. J Gastroenterol. 2016. doi:10.1007/s00535-016-1203-3. Mabe K, Kato M, Oba K, et al. A prospective, multicenter survey on the validity of shorter periendoscopic cessation of antithrombotic agents in Japan. J Gastroenterol. 2016. doi:10.​1007/​s00535-016-1203-3.
17.
Zurück zum Zitat Boustiere C, Veitch A, Vanbiervliet G, et al. Endoscopy and antiplatelet agents. European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2011;43:445–461.CrossRefPubMed Boustiere C, Veitch A, Vanbiervliet G, et al. Endoscopy and antiplatelet agents. European society of gastrointestinal endoscopy (ESGE) guideline. Endoscopy. 2011;43:445–461.CrossRefPubMed
18.
Zurück zum Zitat Ono S, Fujishiro M, Kodashima S, et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J. Gastroenterol.. 2012;47:770–774.CrossRefPubMed Ono S, Fujishiro M, Kodashima S, et al. Evaluation of safety of endoscopic biopsy without cessation of antithrombotic agents in Japan. J. Gastroenterol.. 2012;47:770–774.CrossRefPubMed
19.
Zurück zum Zitat Saito I, Tsuji Y, Sakaguchi Y, et al. Complications related to gastric endoscopic submucosal dissection and their managements. Clin Endosc.. 2014;47:398–403.CrossRefPubMedPubMedCentral Saito I, Tsuji Y, Sakaguchi Y, et al. Complications related to gastric endoscopic submucosal dissection and their managements. Clin Endosc.. 2014;47:398–403.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Tsuji Y, Ohata K, Ito T, et al. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. World J Gastroenterol.. 2010;16:2913–2917.CrossRefPubMedPubMedCentral Tsuji Y, Ohata K, Ito T, et al. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. World J Gastroenterol.. 2010;16:2913–2917.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Koh R, Hirasawa K, Yahara S, et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc.. 2013;78:476–483.CrossRefPubMed Koh R, Hirasawa K, Yahara S, et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc.. 2013;78:476–483.CrossRefPubMed
22.
Zurück zum Zitat Takeuchi T, Ota K, Harada S, et al. The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol.. 2013;13:136.CrossRefPubMedPubMedCentral Takeuchi T, Ota K, Harada S, et al. The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection. BMC Gastroenterol.. 2013;13:136.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Lim JH, Kim SG, Kim JW, et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? Gastrointest Endosc.. 2012;75:719–727.CrossRefPubMed Lim JH, Kim SG, Kim JW, et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? Gastrointest Endosc.. 2012;75:719–727.CrossRefPubMed
24.
Zurück zum Zitat Matsumura T, Arai M, Maruoka D, et al. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol.. 2014;14:172.CrossRefPubMedPubMedCentral Matsumura T, Arai M, Maruoka D, et al. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol.. 2014;14:172.CrossRefPubMedPubMedCentral
Metadaten
Titel
Multicenter Prospective Study on the Safety of Upper Gastrointestinal Endoscopic Procedures in Antithrombotic Drug Users
verfasst von
Yoshiyasu Kono
Minoru Matsubara
Tatsuya Toyokawa
Ryuta Takenaka
Seiyu Suzuki
Junichirou Nasu
Masao Yoshioka
Masahiro Nakagawa
Motowo Mizuno
Hiroyuki Sakae
Makoto Abe
Tatsuhiro Gotoda
Ko Miura
Hiromitsu Kanzaki
Masaya Iwamuro
Keisuke Hori
Takao Tsuzuki
Masahide Kita
Seiji Kawano
Yoshiro Kawahara
Hiroyuki Okada
Publikationsdatum
03.01.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4437-2

Weitere Artikel der Ausgabe 3/2017

Digestive Diseases and Sciences 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.